NanoCarrier's core technology, micellar nanoparticles technology, was proposed and has been researched by Professor Kazunori Kataoka of University of Tokyo, Professor Teruo Okano of Tokyo Women's Medical University and Associate professor Masayuki Yokoyama of the Jikei University. The aforementioned professors demonstrated that when drug-encapsulating micellar nanoparticles were intravenously administered, the particles could function as stable drug carriers in the bloodstream and they accumulated in cancerous tissues.
